Power supply control in a mobile portable device
    11.
    发明授权
    Power supply control in a mobile portable device 有权
    移动便携式设备中的电源控制

    公开(公告)号:US08046610B2

    公开(公告)日:2011-10-25

    申请号:US12159583

    申请日:2006-03-23

    IPC分类号: G06F1/32 G06F1/26

    摘要: The present invention provides a mobile portable device comprising a network communication module, a power-on circuit, a switching power supply, a system power supply and external battery and a calculation unit, wherein the system power supply and external battery constantly supply power to the network communication module by using an external AC power supply or the power of the battery, when the mobile portable device is in a power-off/sleep state, and when the power-on circuit detects that the network communication module has received information from a network, it activates the switching power supply to supply power to the mobile portable device and thus put the mobile portable device into an operating state. By supplying power to the network communication module in the power-off/sleep state of the notebook computer, the computer can be in the network communication state at any time and thus will not miss any information transmitted over the network.

    摘要翻译: 本发明提供了一种移动便携式设备,包括网络通信模块,通电电路,开关电源,系统电源和外部电池以及计算单元,其中系统电源和外部电池不断向 网络通信模块,当移动便携式设备处于断电/休眠状态时,当电源接通电路检测到网络通信模块已经接收到来自网络通信模块的信息时,使用外部AC电源或电池的电力, 网络,其激活开关电源以向移动便携式设备供电,从而将移动便携式设备置于操作状态。 通过在笔记本计算机的断电/睡眠状态下向网络通信模块供电,计算机可以在任何时间处于网络通信状态,因此不会错过通过网络发送的任何信息。

    Peelable sealant containing thermoplastic composite blends for packaging applications
    12.
    发明授权
    Peelable sealant containing thermoplastic composite blends for packaging applications 有权
    含有热塑性复合材料混合物的可剥离密封剂用于包装应用

    公开(公告)号:US09533472B2

    公开(公告)日:2017-01-03

    申请号:US13449762

    申请日:2012-04-18

    摘要: A packaging system has a peelable seal section which includes a first sealing layer and a second sealing layer such that the first sealing layer contacts the second sealing layer to form a peelable seal. The first sealing layer includes thermoplastic polymer or a blend of thermoplastic polymers, an organoclay dispersed within the thermoplastic polymer, a first additional inorganic additive component dispersed within the thermoplastic polymer and a second additional inorganic additive component dispersed within the thermoplastic polymer. The first additional additive component and/or the second additional additive component is selected from the group consisting of calcium carbonate, hydrated magnesium silicate (talc), magnesium carbonate, titanium oxide, magnesium oxide, magnesium sulfate, barium sulfate, barium aluminates, barium borate, barium silicate and combinations thereof.

    摘要翻译: 包装系统具有可剥离密封部分,其包括第一密封层和第二密封层,使得第一密封层接触第二密封层以形成可剥离的密封。 第一密封层包括热塑性聚合物或热塑性聚合物的共混物,分散在热塑性聚合物内的有机粘土,分散在热塑性聚合物内的第一另外的无机添加剂组分和分散在热塑性聚合物内的第二另外的无机添加剂组分。 第一附加添加剂组分和/或第二另外的添加剂组分选自碳酸钙,水合硅酸镁(滑石),碳酸镁,氧化钛,氧化镁,硫酸镁,硫酸钡,铝酸钡,硼酸钡 ,硅酸钡及其组合。

    Ex vivo and in vivo methods and related compositions for regenerating hematopoietic stem cell populations
    13.
    发明授权
    Ex vivo and in vivo methods and related compositions for regenerating hematopoietic stem cell populations 有权
    用于再生造血干细胞群体的离体和体内方法和相关组合物

    公开(公告)号:US09284530B2

    公开(公告)日:2016-03-15

    申请号:US13342628

    申请日:2012-01-03

    IPC分类号: A61K38/00 C12N5/00 C12N5/0789

    摘要: Various embodiments provide methods and related compositions for increasing the population size of hematopoietic stem cells (HSCs) in patients that may benefit from reconstitution of stem cells and/or differentiated cells of the blood lineage. The present methods enable the production of HSCs ex vivo and in vivo by reducing latexin expression and/or latexin activity within HSC exposed to various antagonists. Inhibition of latexin expression and/or latexin activity by various antagonists can promote HSC proliferation and/or inhibit HSC apoptosis. Antagonists that can reduce latexin expression and/or latexin activity can be utilized to regenerate endogenous HSCs within patients affected with disorders, diseases, cancers, or therapies for such conditions, that result in the depletion or reduction in HSCs.

    摘要翻译: 各种实施方案提供用于增加可能受益于重建血细胞系干细胞和/或分化细胞的患者中造血干细胞(HSC)的群体大小的方法和相关组合物。 本发明的方法能够通过降低暴露于各种拮抗剂的HSC内的乳胶蛋白表达和/或胶乳活性而离体和体内生产HSC。 通过各种拮抗剂抑制胶原蛋白表达和/或胶乳活性可促进HSC增殖和/或抑制HSC凋亡。 可以利用可以降低乳胶蛋白表达和/或乳胶蛋白活性的拮抗剂来再生患有疾病,疾病,癌症或这些病症的治疗的患者内源性HSC,导致HSC的消耗或减少。

    Oligomer-modified layered inorganic compounds and their use in nanocomposites
    15.
    发明申请
    Oligomer-modified layered inorganic compounds and their use in nanocomposites 有权
    低聚物改性层状无机化合物及其在纳米复合材料中的应用

    公开(公告)号:US20050137288A1

    公开(公告)日:2005-06-23

    申请号:US10743115

    申请日:2003-12-22

    摘要: Intercalates, exfoliates thereof, and nanocomposite compositions are formed by intercalating a layered silicate material, e.g., a phyllosilicate, with an oligomer or polymer intercalant that is a reaction product of at least one diamine with at least one dicarboxylic acid, to form a polyamide oligomer containing a xylylenediamine component. The oligomer or polymer may be formed in-situ by contacting the layered phyllosilicate with polymerizable monomer reactants using conditions to cause reaction and polymerization in the intercalating composition and intercalation of the resulting oligomer and/or polymer, between platelet layers of the phyllosilicate. An amine functionality of the oligomer or polymer is protonated for ion-exchange with interlayer cations of the phyllosilicate to bond the intercalant to the phyllosilicate platelet, at the protonated amine, at a negative charge site previously occupied by the interlayer cations.

    摘要翻译: 通过将层状硅酸盐材料(例如页硅酸盐)与作为至少一种二胺与至少一种二羧酸的反应产物的低聚物或聚合物嵌入剂嵌入以形成聚酰胺低聚物形成插层,去角质和纳米复合组合物 含有苯二甲胺成分。 低聚物或聚合物可以通过使分层的页硅酸盐与可聚合的单体反应物接触的条件在原位形成,使得在插层组合物中引起反应和聚合并在页硅酸盐的血小板层之间插入所得的低聚物和/或聚合物。 低聚物或聚合物的胺官能团被质子化,以与页硅酸盐的层间阳离子进行离子交换,以在层状阳离子预先占据的负电荷位置处将质子化的胺键合至页硅酸盐片晶。

    Intercalates, exfoliates and concentrates thereof formed with low molecular weight; nylon intercalants polymerized in-situ via ring-opening polymerization
    16.
    发明授权
    Intercalates, exfoliates and concentrates thereof formed with low molecular weight; nylon intercalants polymerized in-situ via ring-opening polymerization 失效
    插层,去角质和浓缩物形成低分子量; 通过开环聚合原位聚合的尼龙嵌入剂

    公开(公告)号:US06906127B2

    公开(公告)日:2005-06-14

    申请号:US10214672

    申请日:2002-08-08

    IPC分类号: C08K9/08 C08K3/34

    摘要: Nylon-intercalated (concentrate nylon), layered silicates, in concentrated form, containing at least 6% to about 40% by weight layered silicate, preferably about 8% to about 30% by weight layered silicate, intercalated with a nylon that is polymerized while in contact with the clay, during ring-opening polymerization of the nylon reactants (monomers) and melt processing. The in-situ nylon polymerization reaction to form the concentrate nylon is continued until the number average molecular weight (Mn) of the nylon is about 25,000 or less, preferably 15,000 or less, more preferably about 5,000-10,000, to maintain melt processability of the resulting concentrate.

    摘要翻译: 尼龙插层(浓缩尼龙),层状硅酸盐,浓缩形式,含有至少6重量%至约40重量%的层状硅酸盐,优选约8重量%至约30重量%的层状硅酸盐,插入与聚合的尼龙 在尼龙反应物(单体)的开环聚合过程中和粘土接触并进行熔融加工。 继续形成浓缩尼龙的原位尼龙聚合反应直到尼龙的数均分子量(Mn)为约25,000或更小,优选为15,000或更小,更优选为约5,000-10,000,以保持所述尼龙的熔融加工性 导致浓缩。

    Ex vivo and in vivo methods and related compositions for generating hematopoietic stem cell populations
    18.
    发明授权
    Ex vivo and in vivo methods and related compositions for generating hematopoietic stem cell populations 失效
    用于产生造血干细胞群的离体和体内方法和相关组合物

    公开(公告)号:US08110184B2

    公开(公告)日:2012-02-07

    申请号:US11540641

    申请日:2006-10-02

    IPC分类号: A61K35/14 C12N5/08

    摘要: Various embodiments provide methods and related compositions for increasing the population size of hematopoietic stem cells (HSCs) in patients that may benefit from reconstitution of stem cells and/or differentiated cells of the blood lineage. The present methods enable the production of HSCs ex vivo and in vivo by reducing latexin expression and/or latexin activity within HSC exposed to various antagonists. Inhibition of latexin expression and/or latexin activity by various antagonists can promote HSC proliferation and/or inhibit HSC apoptosis. Antagonists that can reduce latexin expression and/or latexin activity can be utilized to regenerate endogenous HSCs within patients affected with disorders, diseases, cancers, or therapies for such conditions, that result in the depletion or reduction in HSCs.

    摘要翻译: 各种实施方案提供用于增加可能受益于重建血细胞系干细胞和/或分化细胞的患者中造血干细胞(HSC)的群体大小的方法和相关组合物。 本发明的方法能够通过降低暴露于各种拮抗剂的HSC内的乳胶蛋白表达和/或胶乳活性而离体和体内生产HSC。 通过各种拮抗剂抑制胶原蛋白表达和/或胶乳活性可促进HSC增殖和/或抑制HSC凋亡。 可以利用可以降低乳胶蛋白表达和/或乳胶蛋白活性的拮抗剂来再生患有疾病,疾病,癌症或这些病症的治疗的患者内源性HSC,导致HSC的消耗或减少。